197 research outputs found
Agronomic biofortification with zinc and iron to enhance nutrient concentrations in mango
Biofortification is a global-scale agricultural approach that can improve human nutrition. Agronomic biofortification is viewed as a quick-fix and supplemental approach. Agronomic biofortification, especially foliar application, is highly effective for zinc and iron. A field experiment on agronomic biofortification of zinc and iron micronutrients in mango cv. Kesar was carried out in 2016-2017 at the Regional Horticultural Research Station, ASPEE College of Horticulture and Forestry, Navsari Agricultural University, Navsari (Gujarat). The experiment was arranged in a completely randomized design (CRD) with three replications containing 9 treatments. The results show that foliar application of ZnSO4 and FeSO4 (0.5% each) resulted in higher N (48.73 mg/100 g) and K (94.17 mg/100 g) in the pulp and P (0.056%) in the peel of mango. The iron (Fe) and zinc (Zn) contents in pulp and peel were highest in treatment T9 (0.50% FeSO4 + 0.50% ZnSO4), which was on par with those in treatment T8 (0.50% FeSO4 + 0.25% ZnSO4)
Recommended from our members
Best practice standards for the delivery of NHS infection services in the United Kingdom
Infection expertise in the NHS has historically been provided predominantly by hospital-based medical microbiologists responsible for provision of diagnostic services and advice to front-line clinicians. While most hospitals had consultant-led microbiology departments, infectious iiseases departments were based in a small number of specialist centres. The demand for infection expertise is growing in the NHS, driven by advances in medical care, increasing awareness of the impact of antibiotic resistant and healthcare associated infections and threats from emerging infectious diseases. At the same time diagnostic services are being reorganised into pathology networks. The Combined Infection Training (CIT) is delivering a consultant workforce with expertise both in laboratory diagnostic practice and delivery of direct patient care. These changes create challenges for delivery of high quality infection expertise equitably across the NHS. They also offer an opportunity to shape infection services to meet clinical and laboratory demands. To date there has not been an attempt to bring together a single set of best practice guidelines for the requirements of an infection service. This document sets out seven standards. These are written to be practical and flexible according to the diverse ways in which infection expertise may be required across the NHS. It has been prepared by the Clinical Services Committee of the British Infection Association drawing on published evidence and guidance where they exist and on the group's extensive experience of delivering infection services in hospitals across the NHS. It was then refined with input from the RCP Joint Specialist committee (JSC) and the RCPath Specialist Advisory Committee (SAC) and through consultation with the RCPath membership. It has been endorsed by the Royal College of Pathologists and the Royal College of Physicians. It will be reviewed annually by the CSC and updated as additional evidence becomes available
Cryoballoon pulmonary vein isolation as first-line treatment of typical atrial flutter: long-term outcomes of the CRAFT trial
\ua9 The Author(s) 2024.Background: CRAFT was an international, multicentre, randomised controlled trial across 11 sites in the United UK and Switzerland. Given the evidence that pulmonary vein triggers may be responsible for atrial flutter (AFL) as well as atrial fibrillation (AF), we hypothesised that cryoballoon pulmonary vein isolation (PVI) would provide greater symptomatic arrhythmia reduction than cavotricuspid isthmus (CTI) ablation, whilst also reducing the subsequent burden of AF. Twelve-month outcomes were previously reported. In this study, we report the extended outcomes of the CRAFT study to 36 months. Methods: Patients with typical AFL and no evidence of AF were randomised 1:1 to cryoballoon PVI or radiofrequency CTI. All patients received an implantable loop recorder (ILR) for continuous cardiac rhythm monitoring. The primary outcome was time-to-symptomatic arrhythmia recurrence > 30 s. Secondary outcomes included time-to-first-AF episode â„ 2 min. The composite safety outcome included death, stroke and procedural complications. Results: A total of 113 patients were randomised to cryoballoon PVI (n = 54) or radiofrequency CTI ablation (n = 59). Ninety-one patients reconsented for extended follow-up beyond 12 months. There was no difference in the primary outcome between arms, with the primary outcome occurring in 12 PVI vs 11 CTI patients (HR 0.97; 95% CI 0.43â2.20; p = 0.994). AF â„ 2 min was significantly less frequent in the PVI arm, affecting 26 PVI vs 36 CTI patients (HR 0.48; 95% CI 0.29â0.79; p = 0.004). The composite safety outcome occurred in 5 PVI and 6 CTI patients (p = 0.755). Conclusion: Cryoballoon PVI shows similar efficacy to radiofrequency CTI ablation in reducing symptomatic arrhythmia recurrence in patients presenting with isolated typical AFL but significantly reduces the occurrence of subsequent AF. Graphical Abstract: (Figure presented.)
Fully Automated Electrophysiological Model Personalisation Framework from CT Imaging
International audienceThere has been a recent growing interest for cardiac computed tomography (CT) imaging in the electrophysiological community. This imaging modality indeed allows to locate and assess post-infarct scar heterogeneity, allowing to predict zones of abnormal electrical activity and even personalise EP models. To this end, most of the literature uses manually segmented CT images where one fundamental information is extracted, the myocardial wall thickness. In this paper, we evaluate the impact of using an automated deep learning (DL) methodology to segment the left ventricular wall and extract relevant scar information on the resulting personalised models. Using CT images from 8 patients that were not used during the DL training, we show that the automated segmentation is very similar to the manual one (median Dice score: 0.9). Thickness information obtained this way is also very close to the manual one (median difference: 0.7 mm). A wavefront propagation model personalisation framework based on this thickness information does not show relevant differences in its output (median difference in local activation time: 2 ms), proving its robustness. Bipolar electrograms, simulated through a novel approach, do not differ significantly between manual and automated segmentations (Pearson's r: 0.99)
A genome-wide DNA methylation signature for SETD1B-related syndrome
SETD1B is a component of a histone methyltransferase complex that specifically methylates Lys-4 of histone H3 (H3K4) and is responsible for the epigenetic control of chromatin structure and gene expression. De novo microdeletions encompassing this gene as well as de novo missense mutations were previously linked to syndromic intellectual disability (ID). Here, we identify a specific hypermethylation signature associated with loss of function mutations in the SETD1B gene which may be used as an epigenetic marker supporting the diagnosis of syndromic SETD1B-related diseases. We demonstrate the clinical utility of this unique epi-signature by reclassifying previously identified SETD1B VUS (variant of uncertain significance) in two patients
A genome-wide DNA methylation signature for SETD1B-related syndrome
SETD1B is a component of a histone methyltransferase complex that specifically methylates Lys-4 of histone H3 (H3K4) and is responsible for the epigenetic control of chromatin structure and gene expression. De novo microdeletions encompassing this gene as well as de novo missense mutations were previously linked to syndromic intellectual disability (ID). Here, we identify a specific hypermethylation signature associated with loss of function mutations in the SETD1B gene which may be used as an epigenetic marker supporting the diagnosis of syndromic SETD1B-related diseases. We demonstrate the clinical utility of this unique epi-signature by reclassifying previously identified SETD1B VUS (variant of uncertain significance) in two patients
Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation:A Mechanism in Chronic Lung Allograft Dysfunction
Bacterial infections after lung transplantation cause airway epithelial injury and are associated with an increased risk of developing bronchiolitis obliterans syndrome. The damaged epithelium is a source of alarmins that activate the innate immune system, yet their ability to activate fibroblasts in the development of bronchiolitis obliterans syndrome has not been evaluated. Two epithelial alarmins were measured longitudinally in bronchoalveolar lavages from lung transplant recipients who developed bronchiolitis obliterans syndrome and were compared to stable controls. In addition, conditioned media from human airway epithelial cells infected with Pseudomonas aeruginosa was applied to lung fibroblasts and inflammatory responses were determined. Interleukinâ1 alpha (ILâ1α) was increased in bronchoalveolar lavage of lung transplant recipients growing P. aeruginosa (11.5 [5.4â21.8] vs. 2.8 [0.9â9.4] pg/mL, p < 0.01) and was significantly elevated within 3 months of developing bronchiolitis obliterans syndrome (8.3 [1.4â25.1] vs. 3.6 [0.6â17.1] pg/mL, p < 0.01), whereas high mobility group protein B1 remained unchanged. ILâ1α positively correlated with elevated bronchoalveolar lavage ILâ8 levels (r(2) = 0.6095, p < 0.0001) and neutrophil percentage (r(2) = 0.25, p = 0.01). Conditioned media from P. aeruginosa infected epithelial cells induced a potent proâinflammatory phenotype in fibroblasts via an ILâ1α/ILâ1Râdependent signaling pathway. In conclusion, we propose that ILâ1α may be a novel therapeutic target to limit Pseudomonas associated allograft injury after lung transplantation
Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children
- âŠ